Concurrent Speaker :
Konstantinos Lazaridis, MD

Professor of Medicine, College of Medicine and Science
Center for Individualized Medicine
Mayo Clinic
Rochester, Minnesota

Konstantinos Lazaridis, MD is considered a leader in the area of the genomics of chronic cholestatic liver diseases, namely, Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC). Since 2003, he has established and is the principal investigator of the two national consortia for studying patients afflicted with these diseases. His research group applies the latest genomic and genetic epidemiology approaches to better understand the pathogenesis and improve the therapy of patients with PBC and PSC. This research effort is supported by the NIH. He was elected to the American Society of Clinical Investigation (ASCI) in 2015.

As associate director of the Center for Individualized Medicine in Rochester, Dr. Lazaridis has been instrumental in establishing and expanding the Individualized Medicine Clinic and in directing the Clinomics program that seeks to integrate the latest genomic discoveries into clinical care. Dr. Lazaridis is a physician in the Division of Gastroenterology and Hepatology and the Everett J. and Jane M. Hauck Associate Director, Center for Individualized Medicine, Mayo Clinic in Rochester. Dr. Lazaridis received his medical degree at the University of Ioannina in Greece. He completed his Internal Medicine and Gastroenterology fellowship training at Mayo Clinic and was a Mayo Clinic Scholar in Genomics in the laboratory of Dr. Francis Collins at the National Human Genome Research Institute.


Send Email for Konstantinos Lazaridis